IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rapid Therapeutic Science LA (RTSL)

CUSIP: 753431204 | NYSE | 1 institutional holders

Quarters

Q2 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2022

Tevis Investment Management40
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Tevis Investment Management
40$00.0%ValueMediumPlano, TX2022-08-08